사이드바 영역으로 건너뛰기

게시물에서 찾기2011/01/28

2개의 게시물을 찾았습니다.

  1. 2011/01/28
    엄기영 vs 최문순 ?????
    시다바리
  2. 2011/01/28
    NHS의 종말?(1)
    시다바리

엄기영 vs 최문순 ?????

이광재 강원도지사가 대법원에서 유죄가 확정됨에 따라 지사직을 박탈당하고, 강원도지사 선거가 4.27 재보궐선거판을 달굴 모양이다. 이에 언론과 운동진영일부에서 '엄기영 vs 최문순'의 빅매치(?)를 예측하거나, 바라는 움직임이 일고 있는 모양이다. 얼핏 생각하면 MB정부의 종편 및 미디어, 언론정책을 도마에 올려놓기에 이보다 더 훌륭한 매치가 있을까 싶기도 하고, 그리고 '반MB, 반한나라당전선'을 구축하기에도 나무랄 데가 없을 듯하다. 최문순 의원은 MBC노조위원장 출신이기도 하고, 의정활동에서도 별로 흠잡을 데 없으니, 민주당에 불만을 가진 진보진영에게도 거부감이 거의 없다.

 

하지만 달리 생각하면 이같은 빅매치(의 시도)를 긍정적으로 볼 것만은 아니다 싶다.  문광부장관을 뽑는 게 아니라,  미디어언론정책을 전문성있게 펼칠 국회의원을 뽑는 게 아니라, 강원도지사를 뽑는 선거이기 때문이다.  위와 같은 빅매치를 염두에 두는 의식의 저변에는 알게 모르게 '정치의 미디어화, 미디어의 정치화' '정치의 의인화' 현상이 자리잡고 있는 거 같다.  하긴 어차피 강원도의 도정에 관한 정책이나 전략은 이미 관료와 각 당의 정책에 이미 자리잡고 있을 터 누가 나선들 무슨 상관이랴? 기왕이면 전국적인 관심과 집중을 받을 수 있고, 흥행에도 성공하고, 2012년 총선, 대선을 둔 예선도 치뤄보고 거기에 선거에 승리라도 할 수 있다면 금상첨화. 내가 괜한 시비를 거는 겐가? 다만 진보진영이 인물과 당세가 열악하다는 이유만으로, 그리고 미디어운동진영은 일종의 '이벤트'로 강원도지사 선거에 임하지 않았으면 하는 바램이다.

 

 

 

 

 

 

  

진보블로그 공감 버튼트위터로 리트윗하기페이스북에 공유하기딜리셔스에 북마크

NHS의 종말?

트윗(@cyberdoc73)을 통해 알게 된 Lancet 최신호에 실린 글....

 

The end of our National Health Service

The Lancet
 
There is a crisis in the National Health Service (NHS). The publication of the Health and Social Care Bill last week heralds dramatic changes for the NHS, which will affect the way public health and social care are provided in the UK. Those changes alone will have huge impact, but it is the formation of an NHS Commissioning Board, and commissioning consortia, that will once and for all remove the word “national” from the health service in England. The result, due to come into force in 2013, will be the catastrophic break up of the NHS.
Maintaining the status quo in the NHS is not an option. The NHS is not delivering the care that patients need. Patients with cancer, for example, are less likely to survive in the UK than in Australia, Canada, Sweden, or Norway. Michel Coleman and colleagues' Lancet Article, published last month, reports that the survival of patients with primary colorectal, lung, breast, or ovarian cancer is lower in the UK than in other countries with similar wealth, universal access to health care, and good cancer registration data. Survival is, they argue, “the key index of the overall effectiveness of health services in the management of patients with cancer”.
Despite the huge sums of money pumped into the NHS over the past few years—particularly into the salary budget for staff—translation into benefits for patients is hard to identify. Moreover, the unyielding mountain of bureaucracy that is integral to the NHS stifles innovation, such that it is difficult to design the services needed for local populations.
Will the changes outlined in the Health and Social Care Bill solve these problems within the NHS and improve care for patients? The truth is that we do not know. What we do know is that putting general practitioners (GPs) in charge of commissioning health services for their patients is similar, in some respects, to the fundholding experiment in the 1990s. The principle then was that GPs controlled the budgets to buy the specialist care their patients needed. Fundholding took years to implement, but evidence on short-term or long-term benefits for patients is lacking. In the current Bill, health outcomes, including prevention of premature death, will be the responsibility of the NHS Commissioning Board, which has been asked to publish a business plan and annual reports on progress. That business plan is urgently needed to allow transparent appraisal of how the Board plans to monitor patients' outcomes.
The UK coalition Government has now been in power for about 8 months. Neither the Conservatives nor the Liberal Democrats included the formation of an NHS Commissioning Board, or GPs' commissioning consortia, in their health manifestos on which the electorate voted. The speed of the introduction of the Health and Social Care Bill is surprising, especially given the absence of relevant detail in the health manifestos. The Conservatives promised, if elected, to scrap “politically motivated targets that have no clinical justification” and called themselves the “party of the NHS”—a commitment that seems particularly hollow now.
Since its establishment in July, 1948, the aim of the NHS has been to offer a comprehensive service to improve health and prevent illness, available to all in England and Wales (and then extended throughout the UK), which is largely free of charge. Health care for all, for free, has been the common ethos and philosophy throughout the NHS. On July 3, 1948, in an editorial entitled “Our Service”, The Lancet commented: “Now that everyone is entitled to full medical care, the doctor can provide that care without thinking of his own profit or his patient's loss, and can allocate his efforts more according to medical priority. The money barrier has of course protected him against people who do not really require help, but it has also separated him from people who really do.” Now, GPs will return to the market place and will decide what care they can afford to provide for their patients, and who will be the provider. The emphasis will move from clinical need (GPs' forte) back to cost (not what GPs were trained to evaluate). The ethos will become that of the individual providers, and will differ accordingly throughout England, replacing the philosophy of a genuinely national health service.
Health professionals cannot say that no change is needed—it most certainly is. But there is sufficient uncertainty and concern about the changes outlined in the Health and Social Care Bill to pause, to learn from the past, and to consider what the changes mean for patients' outcomes. As it stands, the UK Government's new Bill spells the end of the NHS.

 

 

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60110-4/fulltext

진보블로그 공감 버튼트위터로 리트윗하기페이스북에 공유하기딜리셔스에 북마크